This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhen Sun - Innovator in Pharmaceutical Compounds
Introduction
Zhen Sun is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific mutations in cancer treatment. His work is crucial in the ongoing battle against various forms of cancer.
Latest Patents
Zhen Sun holds a patent for "Heterocyclic spiro compounds and methods of use." This patent includes compounds of Formula (I) that act as inhibitors of the G12C mutant KRAS protein. The pharmaceutical compositions derived from these compounds are designed to treat disorders such as lung, pancreatic, and colorectal cancers.
Career Highlights
Zhen Sun is currently employed at Amgen Inc., a leading biotechnology company. His role involves research and development focused on innovative treatments for cancer. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Zhen Sun collaborates with various professionals in his field, including his coworker Brian Alan Lanman. Together, they work on advancing research that aims to improve patient outcomes in cancer therapy.
Conclusion
Zhen Sun's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his importance as an inventor. His work continues to pave the way for new therapeutic options that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile